| payload |
{"created_at":"2026-04-06T22:34:24.548 {"created_at":"2026-04-06T22:34:24.548125+00:00","signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","url":"https://www.nasdaq.com/articles/stock-market-today-april-6-soleno-therapeutics-climbs-after-29-billion-all-cash-buyout","value":{"fp":"f819d9ab56875460","kind":"unusual_volume","published_at":"2026-04-06T21:40:08+00:00","source":"Nasdaq Markets","summary":"Soleno Therapeutics (NASDAQ:SLNO), a rare-disease drug developer, closed Monday at $52.26, up 32.31%. The stock\u2019s move reflects Neurocrine Biosciences\u2019 (NASDAQ:NBIX) $53-per-share all-cash acquisition offer for Soleno. Investors are watching for any deal-related regulatory or clo","tickers":[],"title":"Stock Market Today, April 6: Soleno Therapeutics Climbs After $2.9 Billion All-Cash Buyout Agreement","url":"https://www.nasdaq.com/articles/stock-market-today-april-6-soleno-therapeutics-climbs-after-29-billion-all-cash-buyout"}}... |